Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | NPC1 | O15118 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | CES2 | O00748 | 1/20 | 0.58 |
| ▸ | CES1 | P23141 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | CTSD | P07339 | 2/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.53 |
| ▸ | FEN1 | P39748 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL30746017 | 0.98 | GAA (0.62) | GAAMEN1KMT2ATDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL30605742 | 0.98 | GAA (0.62) | GAAMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL30547074 | 0.84 | CTSD (0.63) | GAAMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL239328 | 0.84 | CTSD (0.63) | GAAMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL4033535 | 0.83 | MEN1 (0.68) | MEN1KMT2ATDP1NPC1MAPT | |
| SCHEMBL29970839 | 0.83 | CES2 (0.56) | GAAMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL2646708 | 0.83 | CES2 (0.61) | GAAMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL6450415 | 0.82 | ALDH1A1 (0.70) | GAAMEN1KMT2ATDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL6692325 | 0.81 | CTSD (0.61) | GAAMEN1KMT2ATDP1ALDH1A1 | |
| Hydrazine SCHEMBL14300720 | 0.81 | CTSD (0.61) | GAAMEN1KMT2ATDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 378 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688828-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF | Jubilant DraxImage Inc. (CA) | 2026-02-11 | — | — | EP | claimed |
| WO-2024201255-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF | JUBILANT DRAXIMAGE INC. (CA) | 2024-10-03 | — | — | WO | claimed |
| US-20240316226-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF | JUBILANT DRAXIMAGE INC. (CA) | 2024-09-26 | — | — | US | claimed |
| US-11398630-B2 | Method of generating energy from a hydrazide containing anode fuel, and fuel cell | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2022-07-26 | — | — | US | claimed |
| CN-110041226-B | Compound with AIE characteristics and preparation method and application thereof | 江苏萨瑞斯医疗科技有限公司 | 2022-05-31 | — | — | CN | claimed |
| US-20210005900-A1 | METHOD OF GENERATING ENERGY FROM A HYDRAZIDE CONTAINING ANODE FUEL, AND FUEL CELL | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2021-01-07 | — | — | US | claimed |
| CN-110041226-A | Compound and its preparation method and application with AIE characteristic | 江苏萨瑞斯医疗科技有限公司 | 2019-07-23 | — | — | CN | claimed |
| CN-106397420-B | 3- (5- aryl-1,3,4-oxdiazole -2- bases) asarinin analog derivative, preparation method and application | 郑州大学 | 2018-10-09 | — | — | CN | claimed |
| US-10040741-B2 | Method for manufacturing high purity glycol based compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-08-07 | — | — | US | claimed |
| CN-105669551-B | 7 benzo (c) acridines are to fluorobenzoyl amido thiocarbamide and its preparation method and application | 广西中医药大学 | 2018-04-17 | — | — | CN | claimed |
| CN-106397420-A | 3-(5-aryl-1,3-4-oxadiazole-2-yl)sarisan derivatives, and preparation method and application thereof | 郑州大学 | 2017-02-15 | — | — | CN | claimed |
| US-20160297732-A1 | METHOD FOR MANUFACTURING HIGH PURITY GLYCOL BASED COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-13 | — | — | US | claimed |
| CN-103483300-B | Preparation method of 5-cyanogen-1-(4-fluobenzene)-1,3-dihydrogenated-isobenzofuranone | UNIV SOUTHEAST | 2015-05-06 | — | — | CN | claimed |
| CN-104327043-A | Acridinethioether-typed derivative, preparation method and application thereof | UNIV GUANGXI CHINESE MEDICINE | 2015-02-04 | — | — | CN | claimed |
| CN-102229576-B | Method for synthesizing 1,2,4-triazine compound by using micro-reactor | FUDAN UNIVERSITY (CN) | 2014-10-29 | — | — | CN | claimed |
| CN-103130766-B | Piperine hydrazone or acylhydrazone or sulfonyl hydrazone derivative substances and application for preparing a botanical insecticide | UNIV NORTHWEST A&F | 2014-06-11 | — | — | CN | claimed |
| CN-103483300-A | Preparation method of 5-cyanogen-1-(4-fluobenzene)-1,3-dihydrogenated-isobenzofuranone | UNIV SOUTHEAST | 2014-01-01 | — | — | CN | claimed |
| CN-103130766-A | Piperine hydrazone or acylhydrazone or sulfonyl hydrazone derivative substances and application for preparing a botanical insecticide | UNIV NORTHWEST A&F | 2013-06-05 | — | — | CN | claimed |
| CN-102690258-A | Nitrogenous heterocyclic-imide derivative and preparation method and purpose thereof | HUBEI BIOPESTICIDE ENGINEERING RES CT | 2012-09-26 | — | — | CN | claimed |
| EP-3829559-B1 | INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION | MERCK SHARP & DOHME LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12612409-B2 | Pyrrolopyrimidines as CFTR potentiators | CYSTIC FIBROSIS FOUNDATION (US) | 2026-04-28 | — | — | US | disclosed |
| EP-4688828-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF | Jubilant DraxImage Inc. (CA) | 2026-02-11 | — | — | EP | disclosed |
| US-12539339-B2 | Radiopharmaceutical conjugate compound for diagnosis and/or therapeutic uses thereof | JUBILANT DRAXIMAGE INC. (IN) | 2026-02-03 | — | — | US | disclosed |
| WO-2025264954-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| US-12338243-B2 | P2X7 modulators | JANSSEN PHARMACEUTICA NV (BE) | 2025-06-24 | — | — | US | disclosed |
| US-12331044-B2 | Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection | MERCK SHARP & DOHME LLC (US) | 2025-06-17 | — | — | US | disclosed |
| WO-2024206895-A1 | PYRAZOLO-PYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | RECTIFY PHARMACEUTICALS, INC. (US) | 2024-10-03 | — | — | WO | disclosed |
| WO-2024201255-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF | JUBILANT DRAXIMAGE INC. (CA) | 2024-10-03 | — | — | WO | disclosed |
| US-20240316226-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF | JUBILANT DRAXIMAGE INC. (CA) | 2024-09-26 | — | — | US | disclosed |
| US-20240300932-A1 | N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | GUIZHOU UNIVERSITY (CN) | 2024-09-12 | — | — | US | disclosed |
| CN-114466850-B | [1,2,4] Triazolo [1,5-C ] quinazolin-5-amine | 拜耳股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| EP-4424311-A2 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | Cystic Fibrosis Foundation (US) | 2024-09-04 | — | — | EP | disclosed |
| WO-2024174317-A1 | N-PHENYLIMINE-CONTAINING DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | 贵州大学 | 2024-08-29 | — | — | WO | disclosed |
| CN-118026948-A | Tri-aromatic ring compound and preparation method, pharmaceutical composition and application thereof | 中国药科大学 | 2024-05-14 | — | — | CN | disclosed |
| EP-3541390-B1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | CYSTIC FIBROSIS FOUND (US) | 2024-05-01 | — | — | EP | disclosed |
| CN-117024375-A | Preparation method and application of thiadiazole histone deacetylase inhibitor compound | 济南大学 | 2023-11-10 | — | — | CN | disclosed |
| CN-116887827-A | Compounds and methods for modulating FXR | 拓臻制药公司 | 2023-10-13 | — | — | CN | disclosed |
| US-11731934-B2 | HDAC inhibitor compounds and methods of treatment | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2023-08-22 | — | — | US | disclosed |
| US-20230250100-A1 | Pyrrolopyrimidines as CFTR Potentiators | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. | 2023-08-10 | — | — | US | disclosed |
| WO-2023097386-A1 | SELECTIVE HDAC6-INHIBITING N-ACYLHYDRAZONE COMPOUNDS, METHODS FOR PRODUCING SAME, COMPOSITIONS, USES, TREATMENT METHODS AND KITS | EUROFARMA LABORATÓRIOS S.A (BR) | 2023-06-08 | — | — | WO | disclosed |
| WO-2023097386-A1 | SELECTIVE HDAC6-INHIBITING N-ACYLHYDRAZONE COMPOUNDS, METHODS FOR PRODUCING SAME, COMPOSITIONS, USES, TREATMENT METHODS AND KITS | EUROFARMA LABORATÓRIOS S.A (BR) | 2023-06-08 | — | — | WO | disclosed |
| CN-111165475-B | Hydrogel as carrier for active ingredient and method for preparing the same | 温菲尔德解决方案公司 | 2023-05-26 | — | — | CN | disclosed |
| US-11634391-B2 | Compounds which are inhibitors of Notum | UCL BUSINESS LTD (GB) | 2023-04-25 | — | — | US | disclosed |
| US-20230113037-A1 | [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-04-13 | — | — | US | disclosed |
| CN-115850268-A | Pyrrolopyrimidines as CFTR potentiators | 囊性纤维化基金会 | 2023-03-28 | — | — | CN | disclosed |
| US-20230030414-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED | 2023-02-02 | — | — | US | disclosed |
| CN-110337294-B | Pyrrolopyrimidines as CFTR potentiators | 囊性纤维化基金会 | 2022-11-01 | — | — | CN | disclosed |
| EP-4059932-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | Vertex Pharmaceuticals Incorporated (US) | 2022-09-21 | — | — | EP | disclosed |
| WO-2022180080-A1 | ANTI-PROLIFERATIVE AGENTS | FIRST HEALTH PHARMACEUTICALS B.V. (NL) | 2022-09-01 | — | — | WO | disclosed |
| EP-4050002-A1 | ANTI-PROLIFERATIVE AGENTS | First Health Pharmaceuticals B.V. (NL) | 2022-08-31 | — | — | EP | disclosed |
| US-20220235062-A1 | P2X7 MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2022-07-28 | — | — | US | disclosed |
| US-11398630-B2 | Method of generating energy from a hydrazide containing anode fuel, and fuel cell | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2022-07-26 | — | — | US | disclosed |
| EP-4013508-A1 | [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES | Bayer Aktiengesellschaft (DE) | 2022-06-22 | — | — | EP | disclosed |
| CN-110041226-B | Compound with AIE characteristics and preparation method and application thereof | 江苏萨瑞斯医疗科技有限公司 | 2022-05-31 | — | — | CN | disclosed |
| CN-114466850-A | [1,2,4] triazolo [1,5-C ] quinazolin-5-amines | 拜耳股份有限公司 | 2022-05-10 | — | — | CN | disclosed |
| WO-2022086284-A1 | PROTEIN KINASE INHIBITOR AND USE THEREOF | (주)메디톡스 | 2022-04-28 | — | — | WO | disclosed |
| WO-2022035763-A1 | BORON CONTAINING COMPOUNDS AND THEIR USES | 5METIS, INC. (US) | 2022-02-17 | — | — | WO | disclosed |
| EP-3354650-B1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMA (US) | 2022-02-16 | — | — | EP | disclosed |
| US-11149040-B2 | Fused triazole agonists of the APJ receptor | AMGEN INC. (US) | 2021-10-19 | — | — | US | disclosed |
| US-20210276992-A1 | INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION | MERCK SHARP & DOHME CORP. (US) | 2021-09-09 | — | — | US | disclosed |
| US-20210276992-A1 | INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION | MERCK SHARP & DOHME CORP. (US) | 2021-09-09 | — | — | US | disclosed |
| EP-3843844-A1 | COMPOUNDS | UCL Business Ltd (GB) | 2021-07-07 | — | — | EP | disclosed |
| US-20210171475-A1 | COMPOUNDS | UCL BUSINESS LTD (GB) | 2021-06-10 | — | — | US | disclosed |
| US-20210171534-A1 | Pyrrolopyrimidines as CFTR Potentiators | CYSTIC FIBROSIS FOUNDATION | 2021-06-10 | — | — | US | disclosed |
| EP-3829559-A1 | INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION | Merck Sharp & Dohme Corp. (US) | 2021-06-09 | — | — | EP | disclosed |
| CN-110846675-B | Synthetic method of 2- (5-aryl-1, 3, 4-oxadiazole-2-yl) aniline compound | 阜阳师范大学 | 2021-05-28 | — | — | CN | disclosed |
| CN-111057065-B | Preparation method and application of thienopyrimidine compound | 沈阳药科大学 | 2021-04-23 | — | — | CN | disclosed |
| US-10961232-B2 | Substituted pyrazines as ATR kinase inhibitors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2021-03-30 | — | — | US | disclosed |
| WO-2021028382-A1 | [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-02-18 | — | — | WO | disclosed |
| US-10906890-B2 | Triazole phenyl compounds as agonists of the APJ receptor | AMGEN INC. (US) | 2021-02-02 | — | — | US | disclosed |
| US-20210009509-A1 | HDAC INHIBITOR COMPOUNDS AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2021-01-14 | — | — | US | disclosed |
| US-20210005900-A1 | METHOD OF GENERATING ENERGY FROM A HYDRAZIDE CONTAINING ANODE FUEL, AND FUEL CELL | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2021-01-07 | — | — | US | disclosed |
| WO-2020264581-A1 | BORON CONTAINING COMPOUNDS AND THEIR USES | Boragen, Inc. (US) | 2020-12-30 | — | — | WO | disclosed |
| EP-3541810-B1 | TRIAZOLE PHENYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC (US) | 2020-12-23 | — | — | EP | disclosed |
| US-10807944-B2 | HDAC inhibitor compounds and methods of treatment | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2020-10-20 | — | — | US | disclosed |
| US-20200308189-A1 | FUSED TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. (US) | 2020-10-01 | — | — | US | disclosed |
| CN-109705045-B | Pyrimidine antitumor compound and preparation method and application thereof | 中国医科大学 | 2020-07-14 | — | — | CN | disclosed |
| CN-106496209-B | Compounds useful as inhibitors of ATR kinase | 沃泰克斯药物股份有限公司 | 2020-06-30 | — | — | CN | disclosed |
| CN-106496210-B | Compounds useful as inhibitors of ATR kinase | 沃泰克斯药物股份有限公司 | 2020-06-09 | — | — | CN | disclosed |
| CN-111107846-A | Heteroaryl allosteric modulators of nicotinic acetylcholine receptors | 默沙东公司 | 2020-05-05 | — | — | CN | disclosed |
| CN-106518856-B | Compounds useful as inhibitors of ATR kinase | 沃泰克斯药物股份有限公司 | 2020-04-28 | — | — | CN | disclosed |
| CN-111057065-A | Preparation method and application of thienopyrimidine compound | 沈阳药科大学 | 2020-04-24 | — | — | CN | disclosed |
| WO-2020043866-A1 | COMPOUNDS | UCL BUSINESS LTD (GB) | 2020-03-05 | — | — | WO | disclosed |
| CN-110846675-A | Synthetic method of 2- (5-aryl-1, 3, 4-oxadiazole-2-yl) aniline compound | 阜阳师范大学 | 2020-02-28 | — | — | CN | disclosed |
| WO-2020028150-A1 | INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION | MERCK SHARP & DOHME CORP. (US) | 2020-02-06 | — | — | WO | disclosed |
| WO-2020028150-A1 | INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION | MERCK SHARP & DOHME CORP. (US) | 2020-02-06 | — | — | WO | disclosed |
| US-20200017512-A1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | PFIZER INC. | 2020-01-16 | — | — | US | disclosed |
| US-10479784-B2 | Substituted pyrazin-2-amines as inhibitors of ATR kinase | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2019-11-19 | — | — | US | disclosed |
| CN-110337294-A | Pyrrolopyrimidines as CFTR potentiators | 囊性纤维化基金会治疗公司 | 2019-10-15 | — | — | CN | disclosed |
| EP-3541390-A1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | Cystic Fibrosis Foundation Therapeutics Inc. (US) | 2019-09-25 | — | — | EP | disclosed |
| US-20190284173-A1 | TRIAZOLE PHENYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC. (US) | 2019-09-19 | — | — | US | disclosed |
| EP-3191488-B1 | P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES | JANSSEN PHARMACEUTICA NV (BE) | 2019-08-14 | — | — | EP | disclosed |
| US-20190225621-A1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | CYSTIC FIBROSIS FOUNDATION | 2019-07-25 | — | — | US | disclosed |
| EP-3215505-B1 | PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE | Bayer Pharma AG (DE) | 2019-07-24 | — | — | EP | disclosed |
| CN-110041226-A | Compound and its preparation method and application with AIE characteristic | 江苏萨瑞斯医疗科技有限公司 | 2019-07-23 | — | — | CN | disclosed |
| US-10301315-B2 | Pyrrolopyrimidines as CFTR potentiators | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) | 2019-05-28 | — | — | US | disclosed |
| CN-106146487-B | Pyridylmethyl dithiocarbonic acid hetero-aromatic ring alkyl esters compound and its preparation method and application | 北京大学 | 2019-05-10 | — | — | CN | disclosed |
| US-20190047995-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED | 2019-02-14 | — | — | US | disclosed |
| US-10118930-B2 | Piperidinylpyrazolopyrimidinones and their use | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2018-11-06 | — | — | US | disclosed |
| CN-106397420-B | 3- (5- aryl-1,3,4-oxdiazole -2- bases) asarinin analog derivative, preparation method and application | 郑州大学 | 2018-10-09 | — | — | CN | disclosed |
| US-10040741-B2 | Method for manufacturing high purity glycol based compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-08-07 | — | — | US | disclosed |
| EP-3354650-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | Vertex Pharmaceuticals Incorporated (US) | 2018-08-01 | — | — | EP | disclosed |
| CN-108218848-A | A kind of trifluoromethyl pyridine oxadiazoles（Ether）Analog derivative and its application | 贵州大学 | 2018-06-29 | — | — | CN | disclosed |
| US-20180170922-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED | 2018-06-21 | — | — | US | disclosed |
| US-20180141954-A1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) | 2018-05-24 | — | — | US | disclosed |
| WO-2018094137-A1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) | 2018-05-24 | — | — | WO | disclosed |
| US-20180118749-A1 | P2X7 MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2018-05-03 | — | — | US | disclosed |
| CN-105330651-B | 1 containing (miscellaneous) aryl and piperazine, 2,4- triazolinthione derivatives and preparation method and application | 南开大学 | 2018-05-01 | — | — | CN | disclosed |
| CN-105669551-B | 7 benzo (c) acridines are to fluorobenzoyl amido thiocarbamide and its preparation method and application | 广西中医药大学 | 2018-04-17 | — | — | CN | disclosed |
| CN-104892590-B | Benzheterocycle substitutes 1,3,4 oxadiazole class compounds and its preparation method and application | 华东师范大学 | 2018-03-06 | — | — | CN | disclosed |
| EP-2376485-B1 | PYRAZINE DERIVATIVES USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMA (US) | 2017-12-06 | — | — | EP | disclosed |
| US-20170334917-A1 | PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-11-23 | — | — | US | disclosed |
| EP-3215505-A1 | PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE | Bayer Pharma Aktiengesellschaft (DE) | 2017-09-13 | — | — | EP | disclosed |
| CN-105541748-B | 1,3,4 oxadiazole Mannich base class compounds and preparation and application containing piperazine | 南开大学 | 2017-09-12 | — | — | CN | disclosed |
| CN-104488901-B | A kind of complex composition and preparation of the azoles of bacterium containing methylsulfonyl and antibioticses bactericide | 广西田园生化股份有限公司 | 2017-09-05 | — | — | CN | disclosed |
| CN-104488904-B | A kind of complex composition of the azoles of bacterium containing methylsulfonyl and benzimidazole germicide | 广西田园生化股份有限公司 | 2017-09-05 | — | — | CN | disclosed |
| CN-104488897-B | The complex composition and preparation of the azoles of bacterium containing methylsulfonyl and carbamate fungicide | 广西田园生化股份有限公司 | 2017-09-05 | — | — | CN | disclosed |
| CN-104488900-B | A kind of complex composition of the azoles of bacterium containing methylsulfonyl and anabasine insecticide | 广西田园生化股份有限公司 | 2017-09-05 | — | — | CN | disclosed |
| CN-104488902-B | The azoles of bacterium containing methylsulfonyl and miazines or the complex composition of quinoline series bactericidal agent | 广西田园生化股份有限公司 | 2017-09-05 | — | — | CN | disclosed |
| CN-104488893-B | A kind of complex composition and preparation of the azoles of bacterium containing methylsulfonyl and plant growth regulator | 广西田园生化股份有限公司 | 2017-09-05 | — | — | CN | disclosed |
| CN-104488930-B | A kind of complex composition and preparation of the azoles of bacterium containing methylsulfonyl and Zhongshengmycin | 广西田园生化股份有限公司 | 2017-09-05 | — | — | CN | disclosed |
| CN-107108638-A | Piperidyl PyrazolopyrimidinonecGMP and application thereof | 拜耳制药股份公司 | 2017-08-29 | — | — | CN | disclosed |
| EP-3191488-A1 | P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES | Janssen Pharmaceutica, N.V. (BE) | 2017-07-19 | — | — | EP | disclosed |
| US-9701674-B2 | Substituted pyrazines as ATR kinase inhibitors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2017-07-11 | — | — | US | disclosed |
| US-20170174619-A1 | HDAC INHIBITOR COMPOUNDS AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2017-06-22 | — | — | US | disclosed |
| CN-106866708-A | 1,2,4 triazols [3,4 b] 1,3,4 thiadiazole compounds and its application | 天津理工大学 | 2017-06-20 | — | — | CN | disclosed |
| CN-104488963-B | Compound composition with methanesulphonyl myclobutanil and organic copper bactericide and preparation | 广西田园生化股份有限公司 | 2017-04-19 | — | — | CN | disclosed |
| CN-104542629-B | The complex composition and preparation of a kind of azoles of bacterium containing methylsulfonyl and Inorganic Copper series bactericidal agent | 广西田园生化股份有限公司 | 2017-04-05 | — | — | CN | disclosed |
| CN-104542628-B | The complex composition and preparation of a kind of azoles of bacterium containing methylsulfonyl and Thiodiazole-copper | 广西田园生化股份有限公司 | 2017-03-29 | — | — | CN | disclosed |
| CN-106518856-A | Pyrazine derivatives useful as inhibitors of ATR kinase | 沃泰克斯药物股份有限公司 | 2017-03-22 | — | — | CN | disclosed |
| CN-106496209-A | It is used as the compound of ATR kinase inhibitors | 沃泰克斯药物股份有限公司 | 2017-03-15 | — | — | CN | disclosed |
| CN-106496210-A | It is used as the compound of ATR kinase inhibitors | 沃泰克斯药物股份有限公司 | 2017-03-15 | — | — | CN | disclosed |
| CN-104542627-B | Compound composition containing methanesulfonyl bacteria oxazole and morpholine fungicides and preparation | 广西田园生化股份有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106397420-A | 3-(5-aryl-1,3-4-oxadiazole-2-yl)sarisan derivatives, and preparation method and application thereof | 郑州大学 | 2017-02-15 | — | — | CN | disclosed |
| CN-104672162-B | Preparation method and use of pentadiene ketone compound containing 1,3,4-oxadiazole sulfo-ethyoxyl | 贵州大学 | 2017-01-25 | — | — | CN | disclosed |
| CN-104542625-B | Compound composition containing methanesulfonyl bacteria oxazole and oxazole bactericide and preparation | 广西田园生化股份有限公司 | 2017-01-11 | — | — | CN | disclosed |
| CN-104521991-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of chlorobromide isocyanuric acid and preparation | 广西田园生化股份有限公司 | 2017-01-04 | — | — | CN | disclosed |
| CN-104327043-B | A kind of acridine thioether analog derivative and its production and use | GUANGXI UNIVERSITY OF CHINESE MEDICINE (CN) | 2017-01-04 | — | — | CN | disclosed |
| CN-102300862-B | Compounds useful as inhibitors of ATR kinase | 沃泰克斯药物股份有限公司 | 2016-11-23 | — | — | CN | disclosed |
| CN-106146487-A | Pyridylmethyl dithiocarbonic acid hetero-aromatic ring alkyl esters compound and its production and use | 北京大学 | 2016-11-23 | — | — | CN | disclosed |
| CN-106132958-A | Pyridine 2 amides compound as CB2 agonist | 豪夫迈·罗氏有限公司 | 2016-11-16 | — | — | CN | disclosed |
| US-20160311809-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2016-10-27 | — | — | US | disclosed |
| US-20160297732-A1 | METHOD FOR MANUFACTURING HIGH PURITY GLYCOL BASED COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-13 | — | — | US | disclosed |
| CN-104488926-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of thifluzamide and preparation | 广西田园生化股份有限公司 | 2016-10-05 | — | — | CN | disclosed |
| CN-104488907-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of prothioconazoles and antibacterial | 广西田园生化股份有限公司 | 2016-10-05 | — | — | CN | disclosed |
| CN-104522030-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of imidazoles antibacterial and preparation | 广西田园生化股份有限公司 | 2016-10-05 | — | — | CN | disclosed |
| CN-104488910-B | Containing methylsulfonyl bacterium azoles and the complex composition of triazole bactericidal agent and preparation | 广西田园生化股份有限公司 | 2016-10-05 | — | — | CN | disclosed |
| CN-104488906-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of benziothiazolinone and antibacterial | 广西田园生化股份有限公司 | 2016-10-05 | — | — | CN | disclosed |
| CN-105949181-A | 4-hydroxyl pyrroline-2-ketone derivative containing 1,3,4-oxadiazole and preparation method and application of 4-hydroxyl pyrroline-2-ketone derivative | 贵州大学 | 2016-09-21 | — | — | CN | disclosed |
| CN-104521992-B | Containing methylsulfonyl bacterium azoles and the complex composition of dicarboximide series bactericidal agent and preparation | 广西田园生化股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104488903-B | A kind of containing methylsulfonyl bacterium azoles with the complex composition of the gloomy copper of thiophene | 广西田园生化股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104542695-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of toxic fluoride phosphate and preparation | 广西田园生化股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104488899-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of zinc thiazole and preparation | 广西田园生化股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104585184-B | A kind of complex composition containing methylsulfonyl bacterium azoles | 广西田园生化股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104521988-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of tiger glue adipic acid copper and preparation | 广西田园生化股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104488905-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of S-Ethyl ethylthio sulfonate and preparation | 广西田园生化股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104488928-B | Containing methylsulfonyl bacterium azoles and the complex composition of dithiocarbamate antibacterial and preparation | 广西田园生化股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104621173-B | A kind of composition pesticide containing methylsulfonyl bacterium azoles and preparation | 广西田园生化股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104488896-B | Containing methylsulfonyl bacterium azoles and the complex composition of methoxy acrylic bactericide and preparation | 广西田园生化股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104488898-B | Containing methylsulfonyl bacterium azoles and the complex composition of Xinjunan acetate and antibacterial | 广西田园生化股份有限公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-104488895-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of sym-closene | 广西田园生化股份有限公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-104521990-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of Flutriafol and antibacterial | 广西田园生化股份有限公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-104488894-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of fluopicolide and antibacterial | 广西田园生化股份有限公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-104542626-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of CGA-173506 and preparation | 广西田园生化股份有限公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-104488908-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of Yekuzuo and preparation | 广西田园生化股份有限公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-104521989-B | Containing methylsulfonyl bacterium azoles and the complex composition of acid amide fungicides and preparation | 广西田园生化股份有限公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-104542624-B | A kind of complex composition containing methylsulfonyl bacterium azoles and preparation | 广西田园生化股份有限公司 | 2016-07-27 | — | — | CN | disclosed |
| CN-104522035-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of fenaminosulf and preparation | 广西田园生化股份有限公司 | 2016-07-27 | — | — | CN | disclosed |
| CN-104521987-B | A kind of containing methylsulfonyl bacterium azoles and the complex composition of amide-type insecticide and preparation | 广西田园生化股份有限公司 | 2016-07-27 | — | — | CN | disclosed |
| CN-104488909-B | A kind of complex composition containing methylsulfonyl bacterium azoles and Fluoxastrobin and preparation | 广西田园生化股份有限公司 | 2016-07-06 | — | — | CN | disclosed |
| CN-104488911-B | A kind of insecticidal and bactericidal composition containing methylsulfonyl bacterium azoles and preparation | 广西田园生化股份有限公司 | 2016-06-29 | — | — | CN | disclosed |
| CN-105669551-A | 7-benzo(c)acridine-p-fluorobenzamidothiourea, preparation method and application thereof | 广西中医药大学 | 2016-06-15 | — | — | CN | disclosed |
| US-9365557-B2 | Substituted pyrazin-2-amines as inhibitors of ATR kinase | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2016-06-14 | — | — | US | disclosed |
| CN-104542693-B | A kind of complex composition containing methylsulfonyl bacterium azoles and organophosphorus insecticides and preparation | 广西田园生化股份有限公司 | 2016-06-08 | — | — | CN | disclosed |
| WO-2016071216-A1 | PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-05-12 | — | — | WO | disclosed |
| CN-105541748-A | Piperazine-contained 1,3,4-oxadiazole Mannich base compound, and preparation and application thereof | UNIV NANKAI | 2016-05-04 | — | — | CN | disclosed |
| WO-2016039983-A1 | P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES | JANSSEN PHARMACEUTICA NV (BE) | 2016-03-17 | — | — | WO | disclosed |
| CN-105330651-A | 1,2,4-Triazolethione derivative containing (hetero)aryl group and piperazine, and preparation method and application thereof | UNIV NANKAI | 2016-02-17 | — | — | CN | disclosed |
| CN-103275066-B | 3,5-bis-replaces 4-aminotriazole compounds and synthetic method thereof and application | NANJING NORMAL UNIVERSITY (CN) | 2016-01-27 | — | — | CN | disclosed |
| CN-102690258-B | Nitrogen heterocyclic ring imine derivative and its production and use | HUBEI PROVINCE BIOLOGICAL PESTICIDE ENGINEERING RESEARCH CENTER (CN) | 2015-11-25 | — | — | CN | disclosed |
| CN-105001241-A | S-triazolo-thiadiazole and thiadiazine derivatives, preparation method and application thereof | INST MED BIOTECHNOLOGY CAMS | 2015-10-28 | — | — | CN | disclosed |
| WO-2015153516-A1 | HDAC INHIBITOR COMPOUNDS AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2015-10-08 | — | — | WO | disclosed |
| CN-104892590-A | Benzheterocycle substituted 1,3,4-oxadiazole compound, preparation method and applications thereof | UNIV EAST CHINA NORMAL | 2015-09-09 | — | — | CN | disclosed |
| CN-104744358-A | Pyridine formylhydrazine compounds with insecticidal activity and preparation method and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2015-07-01 | — | — | CN | disclosed |
| CN-104672162-A | Preparation method and use of pentadiene ketone compound containing 1,3,4-oxadiazole sulfo-ethyoxyl | UNIV GUIZHOU | 2015-06-03 | — | — | CN | disclosed |
| CN-104621173-A | Methanesulfonylipconazole-containing pesticide composition and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-05-20 | — | — | CN | disclosed |
| CN-103483300-B | Preparation method of 5-cyanogen-1-(4-fluobenzene)-1,3-dihydrogenated-isobenzofuranone | UNIV SOUTHEAST | 2015-05-06 | — | — | CN | disclosed |
| CN-104585184-A | Compound composition containing methanesulfonyl azole | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-05-06 | — | — | CN | disclosed |
| CN-104542627-A | Compound composition containing methanesulfonyl bacteria oxazole and morpholine fungicides and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-29 | — | — | CN | disclosed |
| CN-104542625-A | Compound composition containing methanesulfonyl bacteria oxazole and oxazole bactericide and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-29 | — | — | CN | disclosed |
| CN-104542695-A | Bactericidal composition containing 2-p-fluorophenyl-5-methylsulfonyl-1,3,4-oxadiazole and Dufulin and preparation containing 2-p-fluorophenyl-5-methylsulfonyl-1,3,4-oxadiazole and Dufulin | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-29 | — | — | CN | disclosed |
| CN-104542693-A | Compound composition containing methanesulfonyl bacteria oxazole and organophosphorus insecticides and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-29 | — | — | CN | disclosed |
| CN-104542628-A | Compound composition containing 2-p-fluorophenyl-5-methylsulfonyl-1,3,4-oxadiazole and thiodiazole copper and preparation containing2-p-fluorophenyl-5-methylsulfonyl-1,3,4-oxadiazole and thiodiazole copper | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-29 | — | — | CN | disclosed |
| CN-104542626-A | Compound composition containing methanesulfonyl bacteria oxazole and fludioxonil | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-29 | — | — | CN | disclosed |
| CN-104542624-A | Compound composition containing methanesulfonyl bacteria oxazole and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-29 | — | — | CN | disclosed |
| CN-104542629-A | Compound composition containing methanesulfonyl bacteria oxazole and inorganic copper fungicides and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-29 | — | — | CN | disclosed |
| CN-104521987-A | 2-(p-fluorophenyl)-5-methanesulfonyl-1,3,4-oxadiazole and amide insecticide-containing compound composition and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-22 | — | — | CN | disclosed |
| CN-104521990-A | Compound composition containing 2-(p-fluorophenyl)-5-methanesulfonyl-1,3,4-oxadiazole and flutriafol and bactericide | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-22 | — | — | CN | disclosed |
| CN-104521992-A | Compound composition containing methanesulfonylconazole and dicarboxyl imide fungicide and preparation of compound composition | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-22 | — | — | CN | disclosed |
| CN-104522030-A | Compound composition containing 2-(p-fluorophenyl)-5-methanesulfonyl-1,3,4-oxadiazole and imidazole bactericides and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-22 | — | — | CN | disclosed |
| CN-104521991-A | Compound composition containing 2-(p-fluorophenyl)-5-methanesulfonyl-1,3,4-oxadiazole and chlorobromoisocyanuric acid and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-22 | — | — | CN | disclosed |
| CN-104521989-A | Compound composition containing 2-(p-fluorophenyl)-5-methanesulfonyl-1,3,4-oxadiazole and amide bactericides and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-22 | — | — | CN | disclosed |
| CN-104522035-A | Compound composition containing 2-(p-fluorophenyl)-5-methanesulfonyl-1,3,4-oxadiazole and leasn and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-22 | — | — | CN | disclosed |
| CN-104521988-A | Compound composition containing 2-(p-fluorophenyl)-5-methanesulfonyl-1,3,4-oxadiazole and Copper(succinate+glutarate+adipate) and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-22 | — | — | CN | disclosed |
| CN-104488905-A | Compound composition containing methanesulphonyl myclobutanil and ethylicin and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488900-A | Compound composition containing methanesulphonyl myclobutanil and neonicotinoid insecticide | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488930-A | Compound composition containing methanesulphonyl myclobutanil and zhongshengmycin and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488899-A | Compound composition containing methanesulphonyl myclobutanil and zinc thiazole and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488894-A | Compound composition containing methanesulphonyl myclobutanil and fluopicolide and bactericide | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488898-A | Compound composition containing methylsulfonylconazole and xinjunan acetate and fungicide | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488928-A | Compound composition containing methylsulfonylconazole and dithiocarbamate fungicide and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488909-A | Compound composition and preparation containing methylsulfonyl azole and azoxystrobin | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488926-A | Compound composition containing methanesulphonyl myclobutanil and thifluzamide and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488911-A | Methylsulfonylconazole-containing insecticidal and bactericidal composition and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488896-A | Compound composition containing methylsulfonylconazole and strobilurin fungicide and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488910-A | Compound composition containing methylsulfonylconazole and triazole fungicide | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488895-A | Compound composition containing methanesulphonyl myclobutanil and trichloroisocyanuric acid | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488963-A | Compound composition with methanesulphonyl myclobutanil and organic copper bactericide and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488904-A | Compound composition containing methanesulphonyl myclobutanil and benzimidazole bactericide | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488903-A | Compound composition containing methanesulphonyl myclobutanil and saisentong | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488897-A | Compound composition containing methanesulphonyl myclobutanil and carbamic acid ester bactericide and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488906-A | Compound composition and bactericide containing methylsulfonyl azole and benziothiazolinone | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488901-A | Compound composition containing methanesulphonyl myclobutanil and antibiotics bactericide and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488907-A | Compound composition and bactericide containing methylsulfonyl azole and prothioconazole | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488902-A | Compound composition containing methylsulfonylconazole and pyrimidine or quinoline fungicide | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104496678-A | Compound composition containing methanesulphonyl myclobutanil and leaf fertilizer and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488908-A | Compound composition and preparation containing methylsulfonyl azole and bismerthiazol | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| CN-104488893-A | Compound composition containing methanesulphonyl myclobutanil and plant growth regulator and preparation | GAUNGXI TIANYUAN BIOCHEMISTRY | 2015-04-08 | — | — | CN | disclosed |
| US-8993570-B2 | Substituted triazolo-pyridazine derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2015-03-31 | — | — | US | disclosed |
| US-8993570-B2 | Substituted triazolo-pyridazine derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2015-03-31 | — | — | US | disclosed |
| US-8993570-B2 | Substituted triazolo-pyridazine derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2015-03-31 | — | — | US | disclosed |
| US-20150051187-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED | 2015-02-19 | — | — | US | disclosed |
| CN-104327043-A | Acridinethioether-typed derivative, preparation method and application thereof | UNIV GUANGXI CHINESE MEDICINE | 2015-02-04 | — | — | CN | disclosed |
| US-20150031661-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2015-01-29 | — | — | US | disclosed |
| CN-102766102-B | Preparation method and application of fluorine-containing triazole compound | UNIV ZHEJIANG TECHNOLOGY | 2014-12-03 | — | — | CN | disclosed |
| CN-102229576-B | Method for synthesizing 1,2,4-triazine compound by using micro-reactor | FUDAN UNIVERSITY (CN) | 2014-10-29 | — | — | CN | disclosed |
| CN-102399225-B | 3-fluorine-containing substituted benzamido-3,4-dihydro-4-imide-5-methylthio-7-ethylthio pyrimido[4,5-d]pyrimidine with herbicidal activity and preparation method thereof | UNIV JIANGXI NORMAL | 2014-09-24 | — | — | CN | disclosed |
| US-8841308-B2 | Pyrazin-2-amines useful as inhibitors of ATR kinase | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-09-23 | — | — | US | disclosed |
| CN-101952275-B | Modulators for amyloid protein beta | HOFFMANN LA ROCHE | 2014-06-18 | — | — | CN | disclosed |
| CN-103130766-B | Piperine hydrazone or acylhydrazone or sulfonyl hydrazone derivative substances and application for preparing a botanical insecticide | UNIV NORTHWEST A&F | 2014-06-11 | — | — | CN | disclosed |
| EP-2282999-B1 | AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME (US) | 2014-05-21 | — | — | EP | disclosed |
| CN-103483300-A | Preparation method of 5-cyanogen-1-(4-fluobenzene)-1,3-dihydrogenated-isobenzofuranone | UNIV SOUTHEAST | 2014-01-01 | — | — | CN | disclosed |
| US-20130317033-A1 | SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2013-11-28 | — | — | US | disclosed |
| CN-103275066-A | 3, 5-disubstituted 4-aminotriazole compound, as well as preparation method and application thereof | UNIV NANJING NORMAL | 2013-09-04 | — | — | CN | disclosed |
| US-8501738-B2 | Substituted triazolo-pyridazine derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2013-08-06 | — | — | US | disclosed |
| US-8501738-B2 | Substituted triazolo-pyridazine derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2013-08-06 | — | — | US | disclosed |
| US-8501738-B2 | Substituted triazolo-pyridazine derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2013-08-06 | — | — | US | disclosed |
| CN-103130766-A | Piperine hydrazone or acylhydrazone or sulfonyl hydrazone derivative substances and application for preparing a botanical insecticide | UNIV NORTHWEST A&F | 2013-06-05 | — | — | CN | disclosed |
| US-8415353-B2 | Amino-quinoxaline and amino-quinoline compounds for use as adenosine A2a receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2013-04-09 | — | — | US | disclosed |
| CN-101514176-B | Compound N-fluorobenzamido-N'-phenylthiocarbamide as well as preparation and application thereof | UNIV NORTHWEST NORMAL | 2012-11-21 | — | — | CN | disclosed |
| CN-101514176-B | Compound N-fluorobenzamido-N'-phenylthiocarbamide as well as preparation and application thereof | UNIV NORTHWEST NORMAL | 2012-11-21 | — | — | CN | disclosed |
| CN-102766102-A | Preparation method and application of fluorine-containing triazole compound | UNIV ZHEJIANG TECHNOLOGY | 2012-11-07 | — | — | CN | disclosed |
| CN-102690258-A | Nitrogenous heterocyclic-imide derivative and preparation method and purpose thereof | HUBEI BIOPESTICIDE ENGINEERING RES CT | 2012-09-26 | — | — | CN | disclosed |
| EP-2454259-A1 | DEUTERIUM-MODIFIED TRIAZOLO-PYRIDAZINE DERIVATIVES AS GABA-A RECEPTOR MODULATORS | Concert Pharmaceuticals Inc. (US) | 2012-05-23 | — | — | EP | disclosed |
| CN-102300862-A | Compounds useful as inhibitors of ATR kinase | — | 2011-12-28 | — | — | CN | disclosed |
| CN-102229576-A | Method for synthesizing 1,2,4-triazine compound by using micro-reactor | UNIV FUDAN | 2011-11-02 | — | — | CN | disclosed |
| EP-2376485-A1 | PYRAZINE DERIVATIVES USEFUL AS INHIBITORS OF ATR KINASE | Vertex Pharmaceuticals Incorporated (US) | 2011-10-19 | — | — | EP | disclosed |
| CN-102216277-A | Substituted benzamides as cannabinoid receptor ligands | ABBOTT LAB | 2011-10-12 | — | — | CN | disclosed |
| US-8013004-B2 | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-09-06 | — | — | US | disclosed |
| US-7947683-B2 | 3-(1,2,4-triazol-3-ylalkyl) azabicyclo (3.1.0) hexane derivatives as modulators of dopamine D3 receptors | GLAXO GROUP LIMTED (GB) | 2011-05-24 | — | — | US | disclosed |
| US-20110105513-A1 | AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME LLC | 2011-05-05 | — | — | US | disclosed |
| US-20110065711-A1 | SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2011-03-17 | — | — | US | disclosed |
| US-20110065711-A1 | SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2011-03-17 | — | — | US | disclosed |
| US-20110065711-A1 | SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2011-03-17 | — | — | US | disclosed |
| EP-1836176-B1 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEROF | BRISTOL MYERS SQUIBB CO (US) | 2011-03-02 | — | — | EP | disclosed |
| EP-2282999-A1 | AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS | Schering Corporation (US) | 2011-02-16 | — | — | EP | disclosed |
| US-20110034472-A1 | Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2011-02-10 | — | — | US | disclosed |
| WO-2011005520-A1 | DEUTERIUM-MODIFIED TRIAZOLO-PYRIDAZINE DERIVATIVES AS GABA-A RECEPTOR MODULATORS | CONCERT PHARMACEUTICALS, INC. (US) | 2011-01-13 | — | — | WO | disclosed |
| WO-2011005520-A1 | DEUTERIUM-MODIFIED TRIAZOLO-PYRIDAZINE DERIVATIVES AS GABA-A RECEPTOR MODULATORS | CONCERT PHARMACEUTICALS, INC. (US) | 2011-01-13 | — | — | WO | disclosed |
| US-20100222318-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-09-02 | — | — | US | disclosed |
| WO-2010071837-A1 | PYRAZINE DERIVATIVES USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-06-24 | — | — | WO | disclosed |
| US-20100113532-A1 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF | BRISTOL-MYERS SQUIBB COMPANY | 2010-05-06 | — | — | US | disclosed |
| US-7642273-B2 | Bridged tricyclic (e.g 9,10-ethanoanthracene) derivatives of (2-carbonylamino)thiazol-5-yloxoacetamides; treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity including obesity, diabetes, inflammatory and immune diseases | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-01-05 | — | — | US | disclosed |
| EP-2124913-A1 | 1-AMINOMETHYL- L- PHENYL- CYCLOHEXANE DERIVATIVES AS DDP-IV INHIBITORS | Novartis AG (CH) | 2009-12-02 | — | — | EP | disclosed |
| CN-101553486-A | Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators | NEUROSEARCH AS (DK) | 2009-10-07 | — | — | CN | disclosed |
| WO-2009109991-A2 | NOVEL HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD., (IN) | 2009-09-11 | — | — | WO | disclosed |
| WO-2009111442-A1 | AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS | SCHERING CORPORATION (US) | 2009-09-11 | — | — | WO | disclosed |
| CN-101514176-A | Compound N-fluorobenzamido-N'-phenylthiocarbamide as well as preparation and application thereof | UNIV NORTHWEST NORMAL (CN) | 2009-08-26 | — | — | CN | disclosed |
| CN-101514176-A | Compound N-fluorobenzamido-N'-phenylthiocarbamide as well as preparation and application thereof | UNIV NORTHWEST NORMAL (CN) | 2009-08-26 | — | — | CN | disclosed |
| CN-101500993-A | 2-aminocarbonylphenylamino-2-phenylacetamides as factor VIIa inhibitors useful as anticoagulants | BRISTOL MYERS SQUIBB CO (US) | 2009-08-05 | — | — | CN | disclosed |
| EP-2079734-A1 | OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | NeuroSearch A/S (DK) | 2009-07-22 | — | — | EP | disclosed |
| US-20090124629-A1 | 3-(1,2,4-TRIAZOL-3YLALKYL) AZABRICLO (3.1.0) HEXANE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | GLAXO GROUP LIMITED (GB) | 2009-05-14 | — | — | US | disclosed |
| US-20090093489-A1 | NOVEL COMPOUNDS FOR TREATMENT OF CANCER AND DISORDERS ASSOCIATED WITH ANGIOGENESIS FUNCTION | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-04-09 | — | — | US | disclosed |
| CN-100465168-C | Oxdiazole derivative and application thereof in electroluminescent material | UNIV EAST CHINA SCIENCE & TECH (CN) | 2009-03-04 | — | — | CN | disclosed |
| WO-2008077597-A1 | 1-AMINOMETHYL- L- PHENYL- CYCLOHEXANE DERIVATIVES AS DDP-IV INHIBITORS | NOVARTIS AG (CH) | 2008-07-03 | — | — | WO | disclosed |
| WO-2008049864-A1 | OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | NEUROSEARCH A/S (DK) | 2008-05-02 | — | — | WO | disclosed |
| US-7358242-B2 | Tetraazabenzo[e]azulene derivatives and analogs thereof | PFIZER INC. (US) | 2008-04-15 | — | — | US | disclosed |
| EP-1869017-A1 | 3- (1,2,4-TRIAZOL-3YLALKYL) AZABRICLO (3.1.0) HEXANE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | GLAXO GROUP LIMITED (GB) | 2007-12-26 | — | — | EP | disclosed |
| US-20070265193-A1 | TETRAAZABENZO[E]AZULENE DERIVATIVES AND ANALOGS THEREOF | PFIZER INC | 2007-11-15 | — | — | US | disclosed |
| US-20070265231-A1 | Hydrazide Compounds for Combating Animal Pests | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-15 | — | — | US | disclosed |
| US-20070232594-A1 | Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2007-10-04 | — | — | US | disclosed |
| EP-1836176-A1 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEROF | Brystol-Myers Squibb Company (US) | 2007-09-26 | — | — | EP | disclosed |
| US-7265104-B2 | Tetraazabenzo[e]azulene derivatives and analogs thereof | PFIZER INC. (US) | 2007-09-04 | — | — | US | disclosed |
| EP-1121361-B1 | PYRAZOLO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME (GB) | 2007-08-29 | — | — | EP | disclosed |
| EP-1819224-A1 | HYDRAZIDE COMPOUNDS FOR COMBATING ANIMAL PESTS | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-22 | — | — | EP | disclosed |
| US-20070179189-A1 | Modulators of the glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof | BRISTOL-MYERS SQUIBB COMPANY | 2007-08-02 | — | — | US | disclosed |
| EP-1813603-A1 | AROMATIC AMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICAL USES OF BOTH | Kissei Pharmaceutical Co., Ltd. (JP) | 2007-08-01 | — | — | EP | disclosed |
| CN-1303115-C | Catalysis system of nitrogen-accessory ingredient of oxygen and nickel in use for polymerizaton of norborene and ramification, preparation method and application | XIANGYANG CATALYST CO LTD YING (CN) | 2007-03-07 | — | — | CN | disclosed |
| CN-1919842-A | Oxdiazole derivative and application thereof in electroluminescent material | UNIV EAST CHINA SCIENCE & TECH (CN) | 2007-02-28 | — | — | CN | disclosed |
| EP-1753766-A1 | TETRAAZABENZO(E)AZULENE DERIVATIVES AND ANALOGS THEREOF | Pfizer Products Inc. (US) | 2007-02-21 | — | — | EP | disclosed |
| EP-1392219-A4 | SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOTOSIS AND THE USE THEREOF | CYTOVIA INC (US) | 2007-01-24 | — | — | EP | disclosed |
| WO-2006108701-A1 | 3- (1,2,4-TRIAZOL-3YLALKYL) AZABRICLO (3.1.0) HEXANE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | GLAXO GROUP LIMITED (GB) | 2006-10-19 | — | — | WO | disclosed |
| WO-2006076702-A1 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ĸB ACTIVITY AND USE THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-07-20 | — | — | WO | disclosed |
| US-7074813-B2 | Substituted N′-(arylcarbonyl)-benzhydrazides, N′-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. (US) | 2006-07-11 | — | — | US | disclosed |
| CN-1260239-C | Fructose spiro-compound with anti-cancer activity | UNIV BEIJING (CN) | 2006-06-21 | — | — | CN | disclosed |
| WO-2006058730-A1 | HYDRAZIDE COMPOUNDS FOR COMBATING ANIMAL PESTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-08 | — | — | WO | disclosed |
| WO-2005116034-A1 | TETRAAZABENZO[E]AZULENE DERIVATIVES AND ANALOGS THEREOF | PFIZER PRODUCTS INC. (US) | 2005-12-08 | — | — | WO | disclosed |
| US-20050267100-A1 | Tetraazabenzo[e]azulene derivatives and analogs thereof | PFIZER INC | 2005-12-01 | — | — | US | disclosed |
| EP-1529045-A2 | NEW COMPOUNDS | Astra Zeneca AB (SE) | 2005-05-11 | — | — | EP | disclosed |
| US-20050075375-A1 | Heterocyclic compounds for treating hepatitis C virus | ANADYS PHARMACEUTICALS, INC. (US) | 2005-04-07 | — | — | US | disclosed |
| US-6872720-B2 | Pyrazolo-triazine derivatives as ligands for gaba receptors | MERCK SHARP & DOHME LTD. | 2005-03-29 | — | — | US | disclosed |
| CN-1563113-A | Catalysis system of nitrogen-accessory ingredient of oxygen and nickel in use for polymerizaton of norborene and ramification, preparation method and application | XIANGYANG CATALYST CO LTD YING (CN) | 2005-01-12 | — | — | CN | disclosed |
| WO-2004110351-A2 | HETEROCYCLIC COMPOUNDS FOR TREATING HEPATITIS C VIRUS | ANADYS PHARMACEUTICALS, INC. (US) | 2004-12-23 | — | — | WO | disclosed |
| US-6828322-B2 | Substituted 1,2, 4-triazolo(4,3-b)pyridazine derivatives; anxiolytic; anticonvulsant; antimigraine | MERCK SHARP & DOHME LTD. | 2004-12-07 | — | — | US | disclosed |
| US-20040186078-A1 | Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. | 2004-09-23 | — | — | US | disclosed |
| CN-1530371-A | Fructose spiro-compound with anti-cancer activity | 北京大学 | 2004-09-22 | — | — | CN | disclosed |
| EP-1430898-A1 | RECEPTOR ANTAGONIST | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-06-23 | — | — | EP | disclosed |
| US-20040110826-A1 | Receptor Antagonists | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-06-10 | — | — | US | disclosed |
| CN-1148357-C | Triazole and imidazole derivative | - | 2004-05-05 | — | — | CN | disclosed |
| US-6716859-B2 | ANTICANCER AGENTS | CYTOVIA, INC. | 2004-04-06 | — | — | US | disclosed |
| US-20040063714-A1 | Triazolo-pyridazine derivatives as ligands for GABA receptors | CARLING WILLIAM ROBERT (GB) | 2004-04-01 | — | — | US | disclosed |
| EP-1392219-A2 | SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOTOSIS AND THE USE THEREOF | Cytovia, Inc. (US) | 2004-03-03 | — | — | EP | disclosed |
| WO-2004014881-A2 | '1,2,4'OXADIAZOLES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 | ASTRA ZENECA AB (SE) | 2004-02-19 | — | — | WO | disclosed |
| US-6630471-B1 | Central nervous system disorders | MERCK SHARP & DOHME LTD. (GB) | 2003-10-07 | — | — | US | disclosed |
| US-6579875-B1 | Treatment of anxiety and convulsions; 7-cyclobutyl-3-(2,6-difluorophenyl)-6-(2-methyl-2H-1,2,4-triazol-3 -ylmethyoxy)-1,2,4-triazolo(4,3-b) pyridazine | MERCK SHARP & DOHME LIMITED | 2003-06-17 | — | — | US | disclosed |
| EP-1090004-B1 | A SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVE, PHARMACEUTICAL COMPOSITIONS MADE THEREFROM | MERCK SHARP & DOHME (GB) | 2003-05-07 | — | — | EP | disclosed |
| EP-0915875-B1 | SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME (GB) | 2003-04-09 | — | — | EP | disclosed |
| US-20030060467-A1 | Pyrazolo-triazine derivatives as ligands for gaba receptors | MERCK SHARP & DOHME LTD. (GB) | 2003-03-27 | — | — | US | disclosed |
| EP-1282623-A1 | PYRAZOLO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LTD. (GB) | 2003-02-12 | — | — | EP | disclosed |
| US-20030013743-A1 | Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CYTOVIA, INC. | 2003-01-16 | — | — | US | disclosed |
| WO-2002089745-A2 | SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF | CYTOVIA, INC. (US) | 2002-11-14 | — | — | WO | disclosed |
| CN-1379777-A | Amino-triazolopyridine derivatives | HOFFMANN LA ROCHE (CH) | 2002-11-13 | — | — | CN | disclosed |
| US-6476030-B1 | Pyrazolo-triazine derivatives as ligands for GABA receptors | MERCK SHARP & DOHME LTD. | 2002-11-05 | — | — | US | disclosed |
| EP-1214322-A2 | AMINO-TRIAZOLOPYRIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2002-06-19 | — | — | EP | disclosed |
| US-6355653-B1 | DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS | HOFFMANN-LA ROCHE INC. | 2002-03-12 | — | — | US | disclosed |
| EP-1150983-A1 | TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LTD. (GB) | 2001-11-07 | — | — | EP | disclosed |
| WO-2001077111-A1 | PYRAZOLO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LIMITED (GB) | 2001-10-18 | — | — | WO | disclosed |
| US-6303597-B1 | FOR THERAPY OF ANXIETY AND CONVULSIONS | MERCK SHARP & DOHME LIMITED (GB) | 2001-10-16 | — | — | US | disclosed |
| EP-1121361-A1 | PYRAZOLO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | Merck Sharp & Dohme Limited (GB) | 2001-08-08 | — | — | EP | disclosed |
| US-6255305-B1 | PSYCHOLOGICAL DISORDERS | MERCK SHARP & DOHME LIMITED (GB) | 2001-07-03 | — | — | US | disclosed |
| CN-1066722-C | Novel acaricidally active tetrazine derivatives | CHINOIN GYOGYSZER ES VEGYESZET (HU) | 2001-06-06 | — | — | CN | disclosed |
| EP-1090004-A1 | A SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVE, PHARMACEUTICAL COMPOSITIONS MADE THEREFROM | Merck Sharp & Dohme Limited (GB) | 2001-04-11 | — | — | EP | disclosed |
| WO-2001017999-A2 | AMINO-TRIAZOLOPYRIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2001-03-15 | — | — | WO | disclosed |
| CN-1281852-A | Triazole and imidazole derivative | HOFFMANN LA ROCHE (CH) | 2001-01-31 | — | — | CN | disclosed |
| EP-1049696-A1 | TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LTD. (GB) | 2000-11-08 | — | — | EP | disclosed |
| EP-1047697-A1 | TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LTD. (GB) | 2000-11-02 | — | — | EP | disclosed |
| WO-2000047582-A1 | TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LIMITED (GB) | 2000-08-17 | — | — | WO | disclosed |
| WO-2000023449-A1 | PYRAZOLO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LIMITED (GB) | 2000-04-27 | — | — | WO | disclosed |
| WO-1999067245-A1 | A SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVE, PHARMACEUTICAL COMPOSITIONS MADE THEREFROM | MERCK SHARP & DOHME LIMITED (GB) | 1999-12-29 | — | — | WO | disclosed |
| WO-1999067245-A1 | A SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVE, PHARMACEUTICAL COMPOSITIONS MADE THEREFROM | MERCK SHARP & DOHME LIMITED (GB) | 1999-12-29 | — | — | WO | disclosed |
| WO-1999037644-A1 | TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LIMITED (GB) | 1999-07-29 | — | — | WO | disclosed |
| WO-1999036423-A1 | TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LIMITED (GB) | 1999-07-22 | — | — | WO | disclosed |
| EP-0915875-A2 | SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LTD. (GB) | 1999-05-19 | — | — | EP | disclosed |
| WO-1998004559-A2 | SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LIMITED (GB) | 1998-02-05 | — | — | WO | disclosed |
| EP-0725776-B1 | 3-ARYL-4-ALKYL AND 4,5-DIALKYL-4H-1,2,4-TRIAZOLES USEFUL AS MEMORY ENHANCERS | MERRELL PHARMA INC (US) | 1997-07-16 | — | — | EP | disclosed |
| EP-0725776-A1 | 3-ARYL-4-ALKYL AND 4,5-DIALKYL-4H-1,2,4-TRIAZOLES USEFUL AS MEMORY ENHANCERS | MERRELL PHARMA INC (US) | 1996-08-14 | — | — | EP | disclosed |
| WO-1995011887-A1 | 3-ARYL-4-ALKYL AND 4,5-DIALKYL-4H-1,2,4-TRIAZOLES USEFUL AS MEMORY ENHANCERS | MERRELL PHARMACEUTICALS INC. (US) | 1995-05-04 | — | — | WO | disclosed |
| US-5334726-A | Controlling weeds | ROHM AND HAAS COMPANY (US) | 1994-08-02 | — | — | US | disclosed |
| EP-0296479-B1 | Fluorobenzoates and process for their production | IHARA CHEMICAL IND CO (JP) | 1994-03-30 | — | — | EP | disclosed |
| EP-0263071-B1 | 2-Substituted-e-fused-[1,2,4]-triazolo[1,5-c] pyrimidines, pharmaceutical compositions, and uses thereof | CIBA-GEIGY AG (CH) | 1992-08-12 | — | — | EP | disclosed |
| US-5134236-A | Analgesics, antidepressants, anticonvulsants | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1992-07-28 | — | — | US | disclosed |
| US-5120347-A | Pre and postemergence | ROHM AND HAAS COMPANY (US) | 1992-06-09 | — | — | US | disclosed |
| US-4999356-A | Analgesics, antidepressants, anticonvulsants | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1991-03-12 | — | — | US | disclosed |
| EP-0217748-B1 | 2-Substituted-e-fused-[1,2,4,]triazolo-[1,5-c]pyrimidines pharmaceutical compositions and uses thereof | CIBA-GEIGY AG (CH) | 1991-02-06 | — | — | EP | disclosed |
| EP-0185256-B1 | TRIAZOLE DERIVATES, THEIR PREPARATION AND THEIR USE AS PESTICIDES | CIBA-GEIGY AG (CH) | 1991-01-30 | — | — | EP | disclosed |
| US-4916253-A | Fluorobenzoates and process for their production | IHARA CHEMICAL INDUSTRY COMPANY, LTD. (JP) | 1990-04-10 | — | — | US | disclosed |
| CN-1039016-A | N '-replacement-N, N '-two replaces the hydrazine insect repellent | ROHM & HAAS (US) | 1990-01-24 | — | — | CN | disclosed |
| US-4831013-A | BENZODIAZEPINE RECEPTOR ANTAGONISTS | CIBA-GEIGY CORPORATION (US) | 1989-05-16 | — | — | US | disclosed |
| EP-0302423-A2 | 1-Phenyl-3-(1-piperazinyl)-1h-indazoles, a process and intermediates for their preparation, and the use thereof as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-02-08 | — | — | EP | disclosed |
| EP-0296479-A2 | Fluorobenzoates and process for their production | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 1988-12-28 | — | — | EP | disclosed |
| US-4788210-A | PESTICIDES | HOFFMANN-LA ROCHE INC. (US) | 1988-11-29 | — | — | US | disclosed |
| WO-1988002370-A1 | 2-SUBSTITUTED-E-FUSED-[1,2,4]TRIAZOLO[1,5-C]PYRIMIDINES PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | CIBA-GEIGY AG (CH) | 1988-04-07 | — | — | WO | disclosed |
| EP-0263071-A1 | 2-Substituted-e-fused-[1,2,4]-triazolo[1,5-c] pyrimidines, pharmaceutical compositions, and uses thereof | CIBA-GEIGY AG (CH) | 1988-04-06 | — | — | EP | disclosed |
| US-4713383-A | ADENOSINE AND BENZODIAZEPINE ANTAGONISTS | CIBA-GEIGY CORPORATION (US) | 1987-12-15 | — | — | US | disclosed |
| EP-0217748-A2 | 2-Substituted-e-fused-[1,2,4,]triazolo-[1,5-c]pyrimidines pharmaceutical compositions and uses thereof | CIBA-GEIGY AG (CH) | 1987-04-08 | — | — | EP | disclosed |
| EP-0185256-A2 | Triazole derivates, their preparation and their use as pesticides | CIBA-GEIGY AG (CH) | 1986-06-25 | — | — | EP | disclosed |
| EP-0181282-A1 | Triazoloquinazoline compounds | CIBA-GEIGY AG (CH) | 1986-05-14 | — | — | EP | disclosed |
| US-4166129-A | AGRICULTURAL AND HORTICULTURAL N-BENZOYL-N'-TRICHLOROETHYLIDENE HYDRAZINE FUNGICIDES | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1979-08-28 | — | — | US | disclosed |
| US-4166129-A | AGRICULTURAL AND HORTICULTURAL N-BENZOYL-N'-TRICHLOROETHYLIDENE HYDRAZINE FUNGICIDES | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1979-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220235062-A1 | P2X7 MODULATORS | P2RX7, P2RX4, P2RX1 | GAA 3113/4885MEN1 3119/4885KMT2A 4518/4885 |
| US-20240300932-A1 | N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | PNMT, NNMT, PAH | GAA 2756/4885MEN1 1534/4885KMT2A 1378/4885 |
| US-20200308189-A1 | FUSED TRIAZOLE AGONISTS OF THE APJ RECEPTOR | TBXA2R, AP3M1, GPBAR1 | GAA 4300/4885MEN1 4086/4885KMT2A 4306/4885 |
| US-20190284173-A1 | TRIAZOLE PHENYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AGTR1, AGTR2, TBXA2R | GAA 4237/4885MEN1 4636/4885KMT2A 3930/4885 |
| US-20090124629-A1 | 3-(1,2,4-TRIAZOL-3YLALKYL) AZABRICLO (3.1.0) HEXANE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | DRD3, HTR3C, TACR2 | GAA 4880/4885MEN1 3837/4885KMT2A 4062/4885 |
| US-10961232-B2 | Substituted pyrazines as ATR kinase inhibitors | ATR, MAP3K5, CHEK1 | GAA 2559/4885MEN1 2596/4885KMT2A 1482/4885 |
| US-12539339-B2 | Radiopharmaceutical conjugate compound for diagnosis and/or therapeutic uses thereof | SLC7A1, SLC39A11, SLC39A3 | GAA 282/4885MEN1 774/4885KMT2A 162/4885 |
| US-12338243-B2 | P2X7 modulators | P2RX7, P2RX4, P2RX1 | GAA 3113/4885MEN1 3119/4885KMT2A 4518/4885 |
| US-20100222318-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | ATR, CHEK1, MAP3K5 | GAA 1759/4885MEN1 2273/4885KMT2A 1708/4885 |
| US-20040063714-A1 | Triazolo-pyridazine derivatives as ligands for GABA receptors | GABRA3, GABBR1, GABRA2 | GAA 4157/4885MEN1 4476/4885KMT2A 1496/4885 |
| US-12331044-B2 | Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection | HDAC1, HDAC11, HDAC10 | GAA 410/4885MEN1 3585/4885KMT2A 88/4885 |
| US-11634391-B2 | Compounds which are inhibitors of Notum | NOTUM, GOT2, GOT1 | GAA 27/4885MEN1 2634/4885KMT2A 4180/4885 |
| US-20130317033-A1 | SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES | GABRA5, GABRA2, GABRA3 | GAA 2767/4885MEN1 3254/4885KMT2A 1758/4885 |
| US-20070265193-A1 | TETRAAZABENZO[E]AZULENE DERIVATIVES AND ANALOGS THEREOF | CCKAR, CCKBR, GLP1R | GAA 975/4885MEN1 1596/4885KMT2A 3726/4885 |
| US-10118930-B2 | Piperidinylpyrazolopyrimidinones and their use | HAMP, SERPINC1, PRSS8 | GAA 4335/4885MEN1 1501/4885KMT2A 3881/4885 |
| US-20170174619-A1 | HDAC INHIBITOR COMPOUNDS AND METHODS OF TREATMENT | HDAC4, HDAC1, HDAC5 | GAA 436/4885MEN1 2835/4885KMT2A 62/4885 |
| US-20040186078-A1 | Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CASP2, CASP1, BCL2 | GAA 2351/4885MEN1 2707/4885KMT2A 2862/4885 |
| US-20210171534-A1 | Pyrrolopyrimidines as CFTR Potentiators | CFTR, P2RX1, P2RX5 | GAA 3288/4885MEN1 4087/4885KMT2A 4318/4885 |
| US-20100113532-A1 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF | NFRKB, NFKBIA, NFKB2 | GAA 3237/4885MEN1 4568/4885KMT2A 3508/4885 |
| US-20210276992-A1 | INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION | HDAC1, HDAC11, HDAC10 | GAA 410/4885MEN1 3585/4885KMT2A 88/4885 |
| US-20150031661-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | ATR, CHEK1, MAP3K5 | GAA 1759/4885MEN1 2273/4885KMT2A 1708/4885 |
| US-20180118749-A1 | P2X7 MODULATORS | P2RX7, P2RX3, P2RX1 | GAA 2522/4885MEN1 3055/4885KMT2A 4030/4885 |
| US-10906890-B2 | Triazole phenyl compounds as agonists of the APJ receptor | AGTR1, AGTR2, TBXA2R | GAA 4237/4885MEN1 4636/4885KMT2A 3930/4885 |
| US-20170334917-A1 | PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE | HAMP, SERPINC1, PRSS8 | GAA 4335/4885MEN1 1501/4885KMT2A 3881/4885 |
| US-11731934-B2 | HDAC inhibitor compounds and methods of treatment | HDAC4, HDAC1, HDAC5 | GAA 436/4885MEN1 2835/4885KMT2A 62/4885 |
| US-20200017512-A1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | CFTR, P2RX1, P2RX5 | GAA 3288/4885MEN1 4087/4885KMT2A 4318/4885 |
| US-20050075375-A1 | Heterocyclic compounds for treating hepatitis C virus | HAVCR2, HCCS, LIPC | GAA 519/4885MEN1 3473/4885KMT2A 3600/4885 |
| US-20190047995-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | ATR, CHEK1, MAP3K5 | GAA 1759/4885MEN1 2273/4885KMT2A 1708/4885 |
| US-20210171475-A1 | COMPOUNDS | GOT2, GOT1, OAT | GAA 36/4885MEN1 2737/4885KMT2A 3672/4885 |
| US-20190225621-A1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | CFTR, P2RX1, P2RX5 | GAA 3288/4885MEN1 4087/4885KMT2A 4318/4885 |
| US-20230030414-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | ATR, CHEK1, MAP3K5 | GAA 1759/4885MEN1 2273/4885KMT2A 1708/4885 |
| US-20230250100-A1 | Pyrrolopyrimidines as CFTR Potentiators | CFTR, P2RX1, P2RX5 | GAA 3288/4885MEN1 4087/4885KMT2A 4318/4885 |
| US-20110034472-A1 | Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function | VEGFA, TEK, MCL1 | GAA 2881/4885MEN1 2560/4885KMT2A 3993/4885 |
| US-20110105513-A1 | AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS | ADORA2A, ADORA1, ADORA3 | GAA 2262/4885MEN1 3052/4885KMT2A 3025/4885 |
| US-10040741-B2 | Method for manufacturing high purity glycol based compound | GK, GMDS, UGCG | GAA 146/4885MEN1 4140/4885KMT2A 1667/4885 |
| US-20110065711-A1 | SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES | GABRA5, GABRA2, GABRA3 | GAA 2767/4885MEN1 3254/4885KMT2A 1758/4885 |
| US-20090093489-A1 | NOVEL COMPOUNDS FOR TREATMENT OF CANCER AND DISORDERS ASSOCIATED WITH ANGIOGENESIS FUNCTION | VEGFA, TEK, MCL1 | GAA 2881/4885MEN1 2560/4885KMT2A 3993/4885 |
| US-20040110826-A1 | Receptor Antagonists | ADRA2C, OPRL1, ADRB1 | GAA 1429/4885MEN1 4885/4885KMT2A 3079/4885 |
| US-20210009509-A1 | HDAC INHIBITOR COMPOUNDS AND METHODS OF TREATMENT | HDAC4, HDAC1, HDAC5 | GAA 436/4885MEN1 2835/4885KMT2A 62/4885 |
| US-12612409-B2 | Pyrrolopyrimidines as CFTR potentiators | CFTR, CLCN2, SLC26A3 | GAA 2850/4885MEN1 4738/4885KMT2A 4855/4885 |
| US-20050267100-A1 | Tetraazabenzo[e]azulene derivatives and analogs thereof | CCKAR, CCKBR, GPR119 | GAA 672/4885MEN1 2268/4885KMT2A 3050/4885 |
| US-20160297732-A1 | METHOD FOR MANUFACTURING HIGH PURITY GLYCOL BASED COMPOUND | GK, GMDS, UGCG | GAA 146/4885MEN1 4140/4885KMT2A 1667/4885 |
| US-20030060467-A1 | Pyrazolo-triazine derivatives as ligands for gaba receptors | GABRA5, GABRA3, GABRA4 | GAA 4466/4885MEN1 4649/4885KMT2A 1302/4885 |
| US-20030013743-A1 | Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | CASP2, CASP1, BCL2 | GAA 2351/4885MEN1 2707/4885KMT2A 2862/4885 |
| US-11149040-B2 | Fused triazole agonists of the APJ receptor | TBXA2R, AP3M1, GPBAR1 | GAA 4300/4885MEN1 4086/4885KMT2A 4306/4885 |
| US-10301315-B2 | Pyrrolopyrimidines as CFTR potentiators | CFTR, P2RX1, P2RX5 | GAA 3468/4885MEN1 4154/4885KMT2A 4332/4885 |
| US-20070265231-A1 | Hydrazide Compounds for Combating Animal Pests | HRH4, CBR3, HRH2 | GAA 3419/4885MEN1 2754/4885KMT2A 3080/4885 |
| US-20180141954-A1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | CFTR, P2RX1, P2RX5 | GAA 3468/4885MEN1 4154/4885KMT2A 4332/4885 |
| US-20070232594-A1 | Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both | AVPR2, AVPR1A, AVPR1B | GAA 2544/4885MEN1 1330/4885KMT2A 3221/4885 |
| US-20230113037-A1 | [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES | AHR, HRH4, HRH1 | GAA 3740/4885MEN1 1941/4885KMT2A 919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.